Microtiter plate immunoenzymometric assay for estrogen receptor

Clinical Chemistry

Volumn 42, Issue 12, 1996, Pages 1955-1960

  Delage, Valérie ^a   Teulon, Jean Marie ^a   Bellanger, Laurent ^a   Seguin, Patrick ^a   Descotes, Françoise ^b   Saez, Simone ^b  

^a CIS Bio International   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

breast cancer; enzyme immunoassay; monoclonal antibodies; radioligand assay; steroid receptor

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; STEROID RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING SITE; BREAST ADENOCARCINOMA; BREAST BIOPSY; BREAST CANCER; CYTOSOL; ENZYME IMMUNOASSAY; HUMAN; HUMAN TISSUE; LIGAND BINDING;

EID: 0029851507     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.12.1955     Document Type: Article

References (27)

1. Auchus RJ, Fuqua SAW. The oestrogen receptor. In: Sheppard MC, Stewart PM, eds. Hormones, enzymes and receptors. In: Baillière's clinical endocrinology and metabolism. International practice and research. London: Baillière Tindall, 1994;8:433-49.
2. Ing NH, O'Malley BW. The steroid hormone receptor superfamily: molecular mechanisms of action. In: Weintraub BD, ed. Molecular endocrinology: basic concepts and clinical correlations. New York: Raven Press, 1995;14:195-215.
3. Ciocca DR, Vargas Roig LM. Estrogen receptors in human nontarget tissues: biological and clinical implications. Endocrine Rev 1995;16:35-62.
4. Horwitz KB, McGuire WL, Pearson OH, Segaloff A. Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 1975;189:726-7.
5. Knight WA, Livingston RB, Gregory EJ, McGuire WL. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 1977;37:4669-71.
6. DeSombre ER, Hugues A, King WJ, Gatley SJ, Schwartz JL, Harper PV. Steroid receptors and breast cancer: current status and new applications for receptor-directed diagnosis and therapy. In: Rich MA, Hager JC, Keydar I, eds. Breast cancer: progress in biology, clinical management and prevention. London: Kluwer Academic, 1989;13:155-69.
7. McGuire WL, Chamness GC, Fuqua SAW. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 1991;5:1571-7.
8. Greene GL, Sobel NB, King WJ, Jensen EV. Immunochemical studies of estrogen receptors. J Steroid Biochem 1984;20:51-6.
9. Al Saati T, Clamens S, Cohen-Knafo E, Faye J-C, Prats H, Coindre J-M, et al. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 1993;55:651-4.
10. Leclercq G, Bojar H, Goussard J, Nicholson RI, Pichon M-F, Piffanelli A, et al. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study. Cancer Res 1986;46(Suppl):4233s-6s.
11. Cren H, Lechevrel C, Roussel G, Goussard J. Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms. J Steroid Biochem Mol Biol 1991;39: 519-27.
12. Romain S, Lainé Bidron C, Martin PM, Magdelénat H, on behalf of the EORTC Study Group. EORTC Receptor Study Group Report. Steroid receptor distribution in 47 892 breast cancers. A collaborative study of 7 European laboratories. Eur J Cancer 1995;31A: 411-7.
13. Krambovitis E, Hatzidakis G, Hatzoglou A, Romain S, Durand A, Stefanakis A, Castanas E. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay. Clin Chem 1995;41:48-53.
14. EORTC Breast Cancer Cooperative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 1980;16:1513-5.
15. Ali S, Lutz Y, Bellocq J-P, Chenard-Neu M-P, Rouyer N, Metzger D. Production and characterization of monoclonal antibodies recognising defined regions of the human oestrogen receptor. Hybridoma 1993;12:391-405.
16. Krust A, Green S, Argos P, Kumar V, Walter P, Bornert J-M, Chambon P. The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J 1986;5:891-7.
17. Abbondanza C, de Falco A, Nigro V, Medici N, Armetta I, Molinari AM, et al. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor. Steroids 1993;58: 4-12.
18. Metzger D, White JH, Chambon P. The human oestrogen receptor functions in yeast. Nature 1988;334:31-6.
19. Sadler WA, Smith MH. A computer program for estimating imprecision characteristics of immunoassays. Comput Biomed Res 1990;23:105-14.
20. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I. J Clin Chem Clin Biochem 1983;21:709-20.
21. Passing H, Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry, part II. J Clin Chem Clin Biochem 1984;22:431-45.
22. Ekins RP. The precision profile: its use in assay design, assessment and quality control. In: Hunter WM, Corrie JET, eds. Immunoassays for clinical chemistry. London: Churchill Livingstone; 1983:76-105.
23. Sluyser M. Mutations in the estrogen receptor gene. Hum Mutat 1995;6:97-103.
24. Pfeffer U, Fecarotta E, Vidali G. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res 1995;55:2158-65.
25. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, et al. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 1991;51: 105-9.
26. Wang Y, Miksicek RJ. Identification of a dominant negative form of the human estrogen receptor. Mol Endocrinol 1991;5:1707-15.
27. Fuqua SAW, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, et al. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 1992;52:483-6.